Form 4: Ardelvx CEO Michael Raab Executes Stock Option and Sells Shares
SEC Form 4
Ardelvx CEO Michael Raab exercised stock options and sold 35,000 shares of common stock on June 13, 2024.
Summary
- On June 13, 2024, Michael Raab, the President and CEO of Ardelvx, Inc., exercised a stock option to acquire 35,000 shares of common stock at a price of $0.99 per share.
- Simultaneously, Raab sold 35,000 shares of common stock at a weighted average price of $6.6498 per share, with prices ranging from $6.601 to $6.73.
- Following these transactions, Raab directly owns 1,270,273 shares of Ardelvx common stock.
- Raab also indirectly owns 24,364 shares through a family trust and 1,000 shares through trusts for his children.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports the CEO's stock transactions. The market's reaction will depend on how investors interpret these actions.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This filing indicates the CEO's recent stock transactions, which can be interpreted in various ways by the market.
Stakeholder Impact
- Shareholders may react to the CEO's stock sale, potentially influencing the stock price.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| July 25, 2012 | Date of the Michael G. Raab Living Trust |
| January 6, 2022 | Date from which the option vests in monthly installments |
| 06/13/2024 | Date of the stock option exercise and share sale |
| 06/17/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.